PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AORT vs. AGL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AORT and AGL is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

AORT vs. AGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Artivion, Inc. (AORT) and agilon health, inc. (AGL). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%OctoberNovemberDecember2025FebruaryMarch
3.40%
-87.10%
AORT
AGL

Key characteristics

Sharpe Ratio

AORT:

0.57

AGL:

-0.35

Sortino Ratio

AORT:

1.05

AGL:

0.08

Omega Ratio

AORT:

1.13

AGL:

1.01

Calmar Ratio

AORT:

0.33

AGL:

-0.34

Martin Ratio

AORT:

2.27

AGL:

-0.71

Ulcer Index

AORT:

7.77%

AGL:

46.52%

Daily Std Dev

AORT:

31.02%

AGL:

94.13%

Max Drawdown

AORT:

-95.72%

AGL:

-96.37%

Current Drawdown

AORT:

-44.45%

AGL:

-90.75%

Fundamentals

Market Cap

AORT:

$984.76M

AGL:

$1.65B

EPS

AORT:

-$0.32

AGL:

-$0.61

Total Revenue (TTM)

AORT:

$388.54M

AGL:

$6.06B

Gross Profit (TTM)

AORT:

$240.96M

AGL:

-$6.91M

EBITDA (TTM)

AORT:

$40.65M

AGL:

-$230.59M

Returns By Period

In the year-to-date period, AORT achieves a -18.08% return, which is significantly lower than AGL's 110.53% return.


AORT

YTD

-18.08%

1M

-23.11%

6M

-5.37%

1Y

17.22%

5Y*

1.46%

10Y*

8.42%

AGL

YTD

110.53%

1M

16.62%

6M

20.85%

1Y

-24.53%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AORT vs. AGL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AORT
The Risk-Adjusted Performance Rank of AORT is 6969
Overall Rank
The Sharpe Ratio Rank of AORT is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of AORT is 6666
Sortino Ratio Rank
The Omega Ratio Rank of AORT is 6464
Omega Ratio Rank
The Calmar Ratio Rank of AORT is 6767
Calmar Ratio Rank
The Martin Ratio Rank of AORT is 7373
Martin Ratio Rank

AGL
The Risk-Adjusted Performance Rank of AGL is 3535
Overall Rank
The Sharpe Ratio Rank of AGL is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of AGL is 3939
Sortino Ratio Rank
The Omega Ratio Rank of AGL is 3939
Omega Ratio Rank
The Calmar Ratio Rank of AGL is 3030
Calmar Ratio Rank
The Martin Ratio Rank of AGL is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AORT vs. AGL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Artivion, Inc. (AORT) and agilon health, inc. (AGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AORT, currently valued at 0.57, compared to the broader market-3.00-2.00-1.000.001.002.003.000.57-0.35
The chart of Sortino ratio for AORT, currently valued at 1.05, compared to the broader market-4.00-2.000.002.004.001.050.08
The chart of Omega ratio for AORT, currently valued at 1.13, compared to the broader market0.501.001.502.001.131.01
The chart of Calmar ratio for AORT, currently valued at 0.45, compared to the broader market0.001.002.003.004.005.000.45-0.34
The chart of Martin ratio for AORT, currently valued at 2.27, compared to the broader market-10.000.0010.0020.002.27-0.71
AORT
AGL

The current AORT Sharpe Ratio is 0.57, which is higher than the AGL Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of AORT and AGL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2025FebruaryMarch
0.57
-0.35
AORT
AGL

Dividends

AORT vs. AGL - Dividend Comparison

Neither AORT nor AGL has paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
AORT
Artivion, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.11%1.04%
AGL
agilon health, inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

AORT vs. AGL - Drawdown Comparison

The maximum AORT drawdown since its inception was -95.72%, roughly equal to the maximum AGL drawdown of -96.37%. Use the drawdown chart below to compare losses from any high point for AORT and AGL. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2025FebruaryMarch
-26.97%
-90.75%
AORT
AGL

Volatility

AORT vs. AGL - Volatility Comparison

The current volatility for Artivion, Inc. (AORT) is 9.25%, while agilon health, inc. (AGL) has a volatility of 20.72%. This indicates that AORT experiences smaller price fluctuations and is considered to be less risky than AGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%OctoberNovemberDecember2025FebruaryMarch
9.25%
20.72%
AORT
AGL

Financials

AORT vs. AGL - Financials Comparison

This section allows you to compare key financial metrics between Artivion, Inc. and agilon health, inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab